Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;48(12):3827-3834.
doi: 10.1007/s00259-021-05524-8. Epub 2021 Aug 28.

International consensus on the use of [18F]-FDG PET/CT in pediatric patients affected by epilepsy

Affiliations

International consensus on the use of [18F]-FDG PET/CT in pediatric patients affected by epilepsy

Mei Tian et al. Eur J Nucl Med Mol Imaging. 2021 Nov.

Abstract

Purpose: Positron emission tomography (PET) with 18F-fluorodeoxyglucose ([18F]-FDG) has been increasingly applied in precise localization of epileptogenic focus in epilepsy patients, including pediatric patients. The aim of this international consensus is to provide the guideline and specific considerations for [18F]-FDG PET in pediatric patients affected by epilepsy.

Methods: An international, multidisciplinary task group is formed, and the guideline for brain [18F]-FDG PET/CT in pediatric epilepsy patients has been discussed and approved, which include but not limited to the clinical indications, patient preparation, radiopharmaceuticals and administered activities, image acquisition, image processing, image interpretation, documentation and reporting, etc. CONCLUSION: This is the first international consensus and practice guideline for brain [18F]-FDG PET/CT in pediatric epilepsy patients. It will be an international standard for this purpose in clinical practice.

Keywords: Brain imaging; Epilepsy; FDG; PET/CT; Pediatric patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Collaborators GE. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:357–75. https://doi.org/10.1016/s1474-4422(18)30454-x . - DOI
    1. Rosati A, De Masi S, Guerrini R. Antiepileptic drug treatment in children with epilepsy. CNS Drugs. 2015;29:847–63. https://doi.org/10.1007/s40263-015-0281-8 . - DOI - PubMed - PMC
    1. Witt JA, Elger CE, Helmstaedter C. Adverse cognitive effects of antiepileptic pharmacotherapy: each additional drug matters. Eur Neuropsychopharmacol. 2015;25:1954–9. https://doi.org/10.1016/j.euroneuro.2015.07.027 . - DOI - PubMed
    1. Dwivedi R, Ramanujam B, Chandra P, Sapra S, Gulati S, Kalaivani M, et al. Surgery for drug-resistant epilepsy in children. N Engl J Med. 2017;377:1639–47. https://doi.org/10.1056/NEJMoa1615335 . - DOI - PubMed
    1. Zhang M, Liu W, Huang P, Lin X, Huang X, Meng H, et al. Utility of hybrid PET/MRI multiparametric imaging in navigating SEEG placement in refractory epilepsy. Seizure. 2020;81:295–303. https://doi.org/10.1016/j.seizure.2020.08.027 . - DOI - PubMed

Substances